Endocrinology, Vol 127, 491-493, Copyright © 1990 by Endocrine Society

ARTICLES

Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7-34)NH2 by substitution of PTH amino acids at positions 10 and 11

RF Nutt, MP Caulfield, JJ Levy, SW Gibbons, M Rosenblatt and RL McKee
Parathyroid Hormone Laboratory, Merck Sharp and Dohme Research Laboratories, West Point, PA 19486.

PTHrP(7-34)NH2 and [D-Trp12]PTHrP(7-34)NH2 have previously been shown to be shown to be more potent antagonists than the corresponding PTH peptide, [Tyr34]bPTH(7-34)NH2. However, these peptides also display partial agonism for adenylate cyclase activity in ROS 17/2.8 cells. In this study, design of a pure potent antagonist of PTH and PTHrP by removal of agonism from PTHrP(7-34)NH2 with retention of antagonist potency was accomplished. Since [Tyr34]bPTH(7-34)NH2 lacks agonist activity, we introduced two amino acids native to the PTH sequence into their respective positions in PTHrP and the potent D-Trp12 analog. [Asn10Leu11]- and [Asn10,leu11,D-Trp12]-PTHrP(7-34)NH2 were found to be 23- and 26-fold more potent as antagonists in ROS cells than PTHrP(7- 34)NH2 and [D-Trp12]PTHrP(7-34)NH2, respectively. In addition, these peptides did not display partial agonism, even in an assay based on highly responsive cells pretreated with dexamethasone and pertussis toxin. In contrast, when the PTHrP sequence Asp10,Lys11 was inserted into [Tyr34]hPTH(7-34)NH2, antagonist potency declined by more than 6- fold and PTH-like agonist activity was installed. These results demonstrate that the activation domain of both PTH and PTHrP can be extended to include the 1-12 region and that the 10-12 region, in addition to the N-terminal hexapeptide, is important not only for receptor binding but also for hormonal signal transduction.

This article has been cited by other articles:

				B. W. Pickard, A. B. Hodsman, L. J. Fraher, and P. H. Watson Type 1 Parathyroid Hormone Receptor (PTH1R) Nuclear Trafficking: Association of PTH1R with Importin {alpha}1 and {beta} Endocrinology, July 1, 2006; 147(7): 3326 - 3332. [Abstract] [Full Text] [PDF]

				A. Ortega, D. Ramila, J. A. Ardura, V. Esteban, M. Ruiz-Ortega, A. Barat, R. Gazapo, R. J. Bosch, and P. Esbrit Role of Parathyroid Hormone-Related Protein in Tubulointerstitial Apoptosis and Fibrosis after Folic Acid-Induced Nephrotoxicity J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1594 - 1603. [Abstract] [Full Text] [PDF]

				I. Talon, V. Lindner, C. Sourbier, E. Schordan, S. Rothhut, M. Barthelmebs, H. Lang, J.-J. Helwig, and T. Massfelder Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo Carcinogenesis, January 1, 2006; 27(1): 73 - 83. [Abstract] [Full Text] [PDF]

				T. M. Murray, L. G. Rao, P. Divieti, and F. R. Bringhurst Parathyroid Hormone Secretion and Action: Evidence for Discrete Receptors for the Carboxyl-Terminal Region and Related Biological Actions of Carboxyl- Terminal Ligands Endocr. Rev., February 1, 2005; 26(1): 78 - 113. [Abstract] [Full Text] [PDF]

				N. Shimizu, T. Dean, J. C. Tsang, A. Khatri, J. T Potts Jr, and T. J. Gardella Novel Parathyroid Hormone (PTH) Antagonists That Bind to the Juxtamembrane Portion of the PTH/PTH-related Protein Receptor J. Biol. Chem., January 21, 2005; 280(3): 1797 - 1807. [Abstract] [Full Text] [PDF]

				S. Fritsch, V. Lindner, S. Welsch, T. Massfelder, M. Grima, S. Rothhut, M. Barthelmebs, and J.-J. Helwig Intravenous Delivery of PTH/PTHrP Type 1 Receptor cDNA to Rats Decreases Heart Rate, Blood Pressure, Renal Tone, Renin Angiotensin System, and Stress-Induced Cardiovascular Responses J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2588 - 2600. [Abstract] [Full Text] [PDF]

				R. J. Midura, X. Su, J. A. Morcuende, M. Tammi, and R. Tammi Parathyroid Hormone Rapidly Stimulates Hyaluronan Synthesis by Periosteal Osteoblasts in the Tibial Diaphysis of the Growing Rat J. Biol. Chem., December 19, 2003; 278(51): 51462 - 51468. [Abstract] [Full Text] [PDF]

				J. L. Martin-Ventura, M. Ortego, P. Esbrit, M. A. Hernandez-Presa, L. Ortega, and J. Egido Possible Role of Parathyroid Hormone-Related Protein as a Proinflammatory Cytokine in Atherosclerosis Stroke, July 1, 2003; 34(7): 1783 - 1789. [Abstract] [Full Text] [PDF]

				P. Divieti, M. R. John, H. Juppner, and F. R. Bringhurst Human PTH-(7-84) Inhibits Bone Resorption in Vitro Via Actions Independent of the Type 1 PTH/PTHrP Receptor Endocrinology, January 1, 2002; 143(1): 171 - 176. [Abstract] [Full Text] [PDF]

				R. C. Gensure, P. H. Carter, B. D. Petroni, H. Juppner, and T. J. Gardella Identification of Determinants of Inverse Agonism in a Constitutively Active Parathyroid Hormone/Parathyroid Hormone-related Peptide Receptor by Photoaffinity Cross-linking and Mutational Analysis J. Biol. Chem., November 9, 2001; 276(46): 42692 - 42699. [Abstract] [Full Text] [PDF]

				A. ValIn, C. Guillen, and P. Esbrit C-Terminal Parathyroid Hormone-Related Protein (PTHrP) (107-139) Stimulates Intracellular Ca2+ through a Receptor Different from the Type 1 PTH/PTHrP Receptor in Osteoblastic Osteosarcoma UMR 106 Cells Endocrinology, July 1, 2001; 142(7): 2752 - 2759. [Abstract] [Full Text] [PDF]

				A. Wang, J. A. Martin, L. A. Lembke, and R. J. Midura Reversible Suppression of in Vitro Biomineralization by Activation of Protein Kinase A J. Biol. Chem., April 6, 2000; 275(15): 11082 - 11091. [Abstract] [Full Text] [PDF]

				P. H. Carter, H. Jüppner, and T. J. Gardella Studies of the N-Terminal Region of a Parathyroid Hormone-Related Peptide(1-36) Analog: Receptor Subtype-Selective Agonists, Antagonists, and Photochemical Cross-Linking Agents Endocrinology, November 1, 1999; 140(11): 4972 - 4981. [Abstract] [Full Text]

				V. Behar, A. Bisello, M. Rosenblatt, and M. Chorev Direct Identification of Two Contact Sites for Parathyroid Hormone (PTH) in the Novel PTH-2 Receptor using Photoaffinity Cross-Linking Endocrinology, September 1, 1999; 140(9): 4251 - 4261. [Abstract] [Full Text]

				M. D. Luck, P. H. Carter, and T. J. Gardella The (1-14) Fragment of Parathyroid Hormone (PTH) Activates Intact and Amino-Terminally Truncated PTH-1 Receptors Mol. Endocrinol., May 1, 1999; 13(5): 670 - 680. [Abstract] [Full Text]

				S. Fukayama, M. Royo, M. Sugita, A. Imrich, M. Chorev, L. J. Suva, M. Rosenblatt, and A. H. Tashjian Jr. New insights into interactions between the human PTH/PTHrP receptor and agonist/antagonist binding Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E297 - E303. [Abstract] [Full Text] [PDF]

				T. J. Gardella, M. D. Luck, G. S. Jensen, T. B. Usdin, and H. Juppner Converting Parathyroid Hormone-related Peptide (PTHrP) into a Potent PTH-2 Receptor Agonist J. Biol. Chem., August 16, 1996; 271(33): 19888 - 19893. [Abstract] [Full Text] [PDF]

				T. J. Gardella, M. D. Luck, A. K. Wilson, H. T. Keutmann, S. R. Nussbaum, J. T. Potts Jr., and H. M. Kronenberg Parathyroid Hormone (PTH)-PTH-related Peptide Hybrid Peptides Reveal Functional Interactions between the 1-14 and 15-34 Domains of the Ligand J. Biol. Chem., March 24, 1995; 270(12): 6584 - 6588. [Abstract] [Full Text] [PDF]

				M. Shimizu, J. T. Potts Jr., and T. J. Gardella Minimization of Parathyroid Hormone. NOVEL AMINO-TERMINAL PARATHYROID HORMONE FRAGMENTS WITH ENHANCED POTENCY IN ACTIVATING THE TYPE-1 PARATHYROID HORMONE RECEPTOR J. Biol. Chem., July 14, 2000; 275(29): 21836 - 21843. [Abstract] [Full Text] [PDF]